Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Shell CEO Van Beurden Prepares to Step Down Next Year

Shell CEO Van Beurden Prepares to Step Down Next Year

-Reuters https://www.reuters.com/business/energy/exclusive-shells-ceo-van-beurden-prepares-step-down-next-year-sources-2022-09-02/

byCharles Gross

September 2, 2022

1 minute read

-Reuters

https://www.reuters.com/business/energy/exclusive-shells-ceo-van-beurden-prepares-step-down-next-year-sources-2022-09-02/

SpaceX’s Starlink Internet Service Now Available On Ocean-Going Vessels: What You Need To Know

By Shanthi Rexaline

July 8, 11:26 AM

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk-owned SpaceX's Starlink satellite internet service is now available for seafarers.

TSLA

Scammers Target Military Veterans in 3M Earplug Settlement Identity Theft Scam

By Vandana Singh

October 17, 2:25 PM

U.S. District Judge M. Casey Rodgers, overseeing the mass tort litigation involving 3M Company's (NYSE: MMM) $6 billion settlement for military earplug-related hearing damage, has warned about an identity theft scam targeting claimants.

MMM

Federal Violations – Chewy Among Companies Selling Unapproved Animal Drugs

By Vandana Singh

December 14, 3:28 PM

The FDA has issued warning letters to Chewy Inc (NYSE:

CHWY

News

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia

By Michael Horton

September 27, 1:51 PM

IHEEZO™ Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14

HROW

Shell CEO Van Beurden Prepares to Step Down Next Year

Related Posts

SpaceX’s Starlink Internet Service Now Available On Ocean-Going Vessels: What You Need To Know

Scammers Target Military Veterans in 3M Earplug Settlement Identity Theft Scam

Federal Violations – Chewy Among Companies Selling Unapproved Animal Drugs

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia